02:10 PM EDT, 06/11/2025 (MT Newswires) -- Health care stocks rose Wednesday afternoon with the NYSE Health Care Index advancing 0.5% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.2%.

The iShares Biotechnology ETF (IBB) eased 0.1%.

In corporate news, AbbVie ( ABBV ) shares gained 1.3% after the US Food and Drug Administration granted a label expansion for Mavyret to treat people with the hepatitis C virus.

Bristol-Myers Squibb ( BMY ) said its phase 3 trial of Sotyktu met its primary goal, showing at least 20% symptom improvement in psoriatic arthritis patients by week 16. The stock rose 0.3%.

Vaxart ( VXRT ) shares jumped 32% after the phase 1 trial of its second-generation oral norovirus vaccine pills met its primary immunological endpoint.